Clinical Trial

Evaluation of 627 in Healthy Adult Subjects

Name: Evaluation of 627 in Healthy Adult Subjects — clinical trial record (NCT07065136)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose phase I clinical study to evaluate the safety, tolerability, PK and immunogenicity of SSGJ-627 in healthy adult subjects after single subcutaneous injection.

Trial Details

NCT Number	NCT07065136
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Healthy Subjects (HS)
Enrollment	108 participants
Start Date	2025-07-20
Primary Completion	2026-09-18 (estimated)
Study Completion	2026-09-18 (estimated)
Updated on ClinicalTrials.gov	2025-07-15